Early Convalescent Plasma for High-Risk Outpatients with Covid-19 | NEJM

Early Convalescent Plasma for High-Risk Outpatients with Covid-19 | NEJM

The administration of Covid-19 convalescent plasma to high-risk outpatients within 1 week after the onset of symptoms of Covid-19 did not prevent disease progression. (SIREN-C3PO ClinicalTrials.gov number, NCT04355767. opens in new tab.)

Comments

Post a Comment

Popular posts from this blog

Dams, taps running dry in northern Mexico amid historic water shortages | Nasdaq

Dams, taps running dry in northern Mexico amid historic water shortages | Nasdaq : Her elderly neighbor is hard of hearing so Maria Luisa Robles, a convenience store worker in the northern Mexican city of Monterrey, shouted the question a second time: Have you run out of water? Human beings have the means, methods, and opportunities to help their fellow human regarding water. They just need to care enough to do it.
Read more

The conflict in Gaza: a view from Israel - The Lancet

The conflict in Gaza: a view from Israel - The Lancet : Khamis Elessi1 writes as a physician describing the deteriorating situation in the Gaza Strip (or Gaza) and pleads to save the residents of Gaza from catastrophe. We share his concern for all the innocent people in Israel and in Gaza. Unfortunately, his Correspondence contains inaccuracies and omits information that paints a very different picture of the catastrophe and its causes.
Read more